Bafna Pharmaceuticals share news and announcements

NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap

₹442.95₹9.00 (1.99%)BSE ₹449.85

Share price at the NSE close on 23 Oct 2026. Previous close ₹451.95.

52-week range of traded prices to 23 Oct 2026

₹94.77Low, 16 Mar 2026₹479.95High, 21 Oct 2026

Delivery only: shares bought must be paid for in full, with no selling on the same day.

Market cap: ₹1,048 Cr2,105th largest listed
P/E: 134.6
P/B: 10.9
Dividend yield: Nonein the last 12 months
ROE: 8.6%
ROCE: 4.0%
Debt to equity: 0.39
Volume, NSE: 1,422

Bafna Pharmaceuticals record dates, bonuses and splits

7 filed, newest first.

Aug 2024
- 30 Aug · Corporate action
  Register of Members & Share Transfer Books of the Company will remain closed from 19-Sep-2024 to 25-Sep-2024 for the purpose of 29th Annual General Meeting. (opens in a new tab)
Jul 2022
- 5 Jul · Corporate action
  Register of Members & Share Transfer Books of the Company will remain closed from 22-Jul-2022 to 28-Jul-2022 for the purpose of Annual general meeting (opens in a new tab)
Nov 2021
- 12 Nov · Corporate action
  3. Raising of funds by way of offer and issue of equity shares to the existing shareholders of the Company on a rights basis (Rights Issue) for an aggregate amount upto INR 50 Crore. The Board has constituted a Rights Issue Committee of Directors for the above purpose and has authorised the Committee to determine the terms of the Rights Issue including the quantum of issue, rights entitlement ratio, issue price, issue size, book closure or record date, entitlement timing of the issue, appointment of intermediaries, etc., in consultation with the Lead Manager to the Right Issue and to decide all other matters relating to the Right Issue. Such details shall be informed and/or announced in due course as and when decided or required, as per applicable statutory provisions and depending upon the market conditions. The above proposal to issue of shares shall be subject to necessary approvals, confirmations and consents as may be necessary and in compliance with applicable law including the provisions of the Securities and Exchange Board of India (lssue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013 and the Rules made there under and as amended.The proposed Rights Issue will be a step towards meeting with the Minimum Public Shareholding requirements and is one of the prescribed methods in accordance with SEBI Circular No. CIR/CFD/CMD/14/2015 dated November 30, 2015, as amended. Accordingly, the Promoter may not participate in the proposed Rights Issue. (opens in a new tab)
Jul 2021
- 26 Jul · Corporate action
  Register of Members & Share Transfer Books of the Company will remain closed from 07-Aug-2021 to 14-Aug-2021 for the purpose of Meeting. (opens in a new tab)
Jun 2020
- 29 Jun · Corporate action
  Register of Members & Share Transfer Books of the Company will remain closed from 25-Jul-2020 to 31-Jul-2020 for the purpose of Meeting. (opens in a new tab)
Aug 2019
- 20 Aug · Corporate action
  Company has fixed Record Date as August 27, 2019 for the purpose of determining the eligible equity shareholders whose equity shares shall stand reduced, pursuant to the Resolution Plan approved by the Hon ble National Company Law Board Tribunal, Chennai Bench vide its Order dated 1st February, 2019 ("Approved Resolution Plan"). (opens in a new tab)
Sep 2017
- 12 Sep · Corporate action
  Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2017 to September 30, 2017 (both days inclusive) for the purpose of Annual General Meeting. (opens in a new tab)

Bafna Pharmaceuticals record dates, bonuses and splits

Aug 2024

Jul 2022

Nov 2021

Jul 2021

Jun 2020

Aug 2019

Sep 2017